Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02262754
Other study ID # B7431006
Secondary ID
Status Completed
Phase Phase 2
First received October 9, 2014
Last updated May 31, 2016
Start date October 2014
Est. completion date August 2015

Study information

Verified date May 2016
Source Pfizer
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

PF-06372865 In Subjects With Chronic Low Back Pain


Recruitment information / eligibility

Status Completed
Enrollment 222
Est. completion date August 2015
Est. primary completion date August 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
PF-06372865
Dose level 1 daily dosing BID for 1 week followed by dose level 2 daily BID for 3 weeks
Placebo
Placebo for PF-06372865 and placebo for naproxen daily
Naproxen
500 mg BID for 4 weeks

Locations

Country Name City State
United States Global Research Anaheim California
United States Better Health Clinical Research, Inc. Atlanta Georgia
United States River Birch Research Alliance, LLC Blue Ridge Georgia
United States Boston Clinical Trials Boston Massachusetts
United States Chicago Anesthesia Associates Chicago Illinois
United States Columbus Regional Research Institute Columbus Georgia
United States Family Medicine center Columbus Georgia
United States Avail Clinical Research, LLC DeLand Florida
United States Altoona Center for Clinical Research Duncansville Pennsylvania
United States S&W Clinical Research Fort Lauderdale Florida
United States Neuro-Pain Medical Center Fresno California
United States Florida Research Network, LLC Gainesville Florida
United States Drug Trials America Hartsdale New York
United States Broward Research Group Hollywood Florida
United States Clinical Trial Network Houston Texas
United States CRC of Jackson Jackson Mississippi
United States Physician's Surgery Center Jackson Mississippi
United States Jacksonville Center for Clinical Research Jacksonville Florida
United States Centex Studies, Inc Lake Charles Louisiana
United States Drug Studies America Marietta Georgia
United States Agave Clinical Research, LLC Mesa Arizona
United States ActivMed Practices & Research, Inc. Methuen Massachusetts
United States Better Health Clinical Research, Inc. Newnan Georgia
United States Better Health Clinical Research, Inc./Georgia Pain & Spine Care, Inc. Newnan Georgia
United States National Clinical Research - Norfolk, Inc. Norfolk Virginia
United States Providence Clinical Research North Hollywood California
United States Compass Research, LLC Orlando Florida
United States Pines Clinical Research Inc. Pembroke Pines Florida
United States Arizona Research Center, Inc. Phoenix Arizona
United States Accord Clinical Research, LLC Port Orange Florida
United States Summit Research Network (Oregon), Inc. Portland Oregon
United States Wake Internal Medicine Consultants, Inc. Raleigh North Carolina
United States Wake Research Associates, LLC Raleigh North Carolina
United States AAIR Research Center Rochester New York
United States Lee Medical Associates, PA San Antonio Texas
United States Progressive Clinical Research San Antonio Texas
United States Southeast Regional Research Group Savannah Georgia
United States Summit Research Network (Seattle) LLC Seattle Washington
United States Arthritis & Rheumatic Care Center South Miami Florida
United States Miami Research Associates South Miami Florida
United States Stamford Therapeutics Consortium Stamford Connecticut
United States Omega Medical Research Warwick Rhode Island
United States Elite Clinical Trials, Incorporate Wildomar California
United States The Center for Clinical Research Winston-Salem North Carolina
United States North Georgia Clinical Research Woodstock Georgia
United States North Georgia Internal medicine Woodstock Georgia

Sponsors (1)

Lead Sponsor Collaborator
Pfizer

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of PF-06372865 vs placebo 4 weeks No
Primary Safety and tolerability of PF-06372865 up to 28 days post last dose Yes
Secondary Efficacy of PF-06372865 vs naproxen 4 weeks No
Secondary Characterize timecourse of analgesia associated with PF-06372865 4 weeks No
Secondary Evaluate PF-06372865 on functional status 4 weeks No
Secondary Evaluate PF-06372865 on learning efficiency 4 weeks No
Secondary Evaluate subject's assessment of the study medication 4 weeks No
Secondary Plasma exposure of PF-06372865 and naproxen 4 weeks No
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3